Webcast Details Apogee Therapeutics’ live webcast of the APG777 Phase 1b asthma interim results will begin on Tuesday, January 6 th at 8:00 a.m. ET. The live webcast can be accessed via this link or ...
Apogee Enterprises (APOG) will release earnings results on Jan. 7, 2026. Analysts expect $1.01/share, down from $1.19/share ...
Apogee Therapeutics develops RORγt-targeted therapies as Nasdaq today highlights clinical-stage biotech activity.
After Johnson & Johnson (JNJ) recently reported that the Phase 2b DUPLEX-AD proof-of-concept study of JNJ-95475939 for the treatment of moderate ...
StockStory.org on MSN
NN, Redwire, Array, Apogee, and Winnebago shares plummet, what you need to know
What Happened? A number of stocks fell in the afternoon session after major indices pulled back from record highs reached the ...
SAN FRANCISCO and WALTHAM, Mass., July 18, 2023 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a biotechnology company advancing differentiated biologics for the treatment of atopic ...
Apogee Therapeutics Inc. (NASDAQ:APGE) stock is experiencing a significant surge, trading almost 29% higher in premarket on Monday. This substantial increase in stock price follows the release of ...
Shares of architectural products and services company Apogee Enterprises (NASDAQ: APOG) rallied 25.5% on Friday, as of 2 p.m. ET. Apogee released second-quarter earnings today. Not only did the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback